Determination of oxeladin citrate in drug combinations
Knopp, C.; Korsatko, W.
Die Pharmazie 37(1): 76-77
1982
ISSN/ISBN: 0031-7144 PMID: 7071116 Document Number: 196875
Document emailed within 1 workday
Related Documents
Borsa, M.; Formento, M.L.; Zoni, G. 1973: Determination of nucleosides in drug combinations Bollettino Chimico Farmaceutico 112(10): 707-713Grieco, C.; Silipo, C.; Vittoria, A. 1975: Determination of chloramphenicol and vitamin C in drug combinations using gas chromatography and non-aqueous titrimetry Bollettino della Societa Italiana di Biologia Sperimentale 51(13): 817-823
Chantarangkul, V.; Tripodi, A.; Clerici, M.; Negri, B.; Mannucci, P.M. 1998: Assessment of the influence of citrate concentration on the International Normalized Ratio (INR) determined with twelve reagent-instrument combinations Thrombosis and Haemostasis 80(2): 258-262
Horváth, Z. 1973: Studies on the causes for drug abuse using ethylmorphine hydrochloride and acetylsalicylic-acid-containing drug combinations Die Pharmazie 28(4): 242-243
Shol'ts, K.F.; Nikolaeva-Romberg, M.I. 1971: Determination of citrate in rats during starvation Biokhimiia 36(2): 249-252
Millán, A.; Conte, A.; García-Raso, A.; Grases, F. 1987: Determination of citrate in urine by simple direct photometry Clinical Chemistry 33(7): 1259-1260
Weclawska, K.; Regosz, A. 1987: Colorimetric determination of pentoxiverine citrate in some pharmaceutical preparations Die Pharmazie 42(7): 483-484
Rass, H. 1996: HIV therapy with drug combinations Deutsche Medizinische Wochenschrift 121(25-26): A36
Glogner, P. 1970: Unfavorable and problematic drug combinations. II Der Internist 11(7): 260-261
Des Lauriers, A.; Puech, A.; Allilaire, J.F. 1982: Drug combinations in the treatment of depression La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 58(42): 2432-2439
Ariëns, E.J. 1973: Drug combinations; feasibilities and limitations Nederlands Tijdschrift Voor Geneeskunde 117(11): 434-451
Soll, D.B.; Weston, J.M. 1979: Ophthalmic fixed-ratio drug combinations American Family Physician 19(4): 156-158
Rustenbeck, I. 2009: Fixed drug combinations--the pros and the cons Medizinische Monatsschrift für Pharmazeuten 32(4): 141-146
Jacquillat, C.; Weil, M.; Goguel, A.; Schaison, G.; Delobel, J.; Gemon, M.F.; Brunel-Kotschi, R.; Teillet, F.; Boiron, M.; Bernard, J. 1971: Chemotherapy of Hodgkin's disease with drug combinations La Presse Medicale 79(12): 513-518
Sivolodskiĭ, E.P. 1976: Method for the microbiological determination of the type and concentration of antibiotics in combinations Antibiotiki 21(4): 338-344
Shishkov, N.; Drumev, D. 1975: Possible synergic action of some drug combinations against Mycoplasma gallisepticum Veterinarno-Meditsinski Nauki 12(5): 98-105
Tschudi-Steiner, I. 1975: When do drug combinations show the danger of side effects Pharmaceutica Acta Helvetiae 50(11): 415-420
Shoshkes, M. 1974: The use of propranolol with various drug combinations in the treatment of essential hypertension Journal of the Medical Society of New Jersey 71(8): 581-583
Srimuang, S.; Prariyachatigul, C.; Chaiprasert, A.; Rungsipanuratn, W.; Tanphaichitra, D. 2000: Antifungal drug combinations for Cryptococcus neoformans and Prototheca spp Journal of the Medical Association of Thailand 83(1): 57-60
Owsley, H.D.; Rusho, W.J. 1997: Compatibility of common respiratory therapy drug combinations International Journal of Pharmaceutical Compounding 1(2): 121-122